Navigation Links
Genstar Capital Promotes J. Ryan Clark to Principal
Date:2/11/2008

m" target="_new">(http://www.gencap.com) is a leading private equity firm that for 20 years has been actively investing in high quality middle-market companies and building value in those businesses by utilizing the expertise of its operating partners. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating partners and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, industrial technology, software, and business services industries.

Contact: Chris Tofalli

Chris Tofalli Public Relations

914-834-4334


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genstar Capital Appoints Mark Hanson to Managing Director
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. AtriCure to Present at Roth Capital Partners 2007 New York Conference
4. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
5. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Advanced Life Sciences Joins NASDAQ Capital Market
10. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
11. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Th...onsistent procedures to allow the public to,see ex...ished today in the,Federal Register http://edocke...will ensure that the best and latest available evi... risk assessments for health,standards regulating ...
(Date:8/29/2008)...iation may have caused chromosomal change that rai... FRIDAY, Aug. 29 (HealthDay News) -- Some Japanese...in Hiroshima and Nagasaki experienced key genetic ...of thyroid cancer, new research indicates. , Pa...o a particular genetic mutation involving the so-c...
(Date:8/29/2008)... LEEDS, England, August 29 /PRNewswire/ --, - MYA...ce for Recent,Big Brother Stars but the big Questi...as, mirrors all around and being on national,telev...ct on how you feel,about the way you look. For man... a reality. Upon leaving the house contestants may...
(Date:8/29/2008)... Dr. Milton Owens and the Co... Southern California to provide protection for cas...on, and the Hispanic community is benefiting. , ...ust 29, 2008 -- Dr. Milton Owens and the Coastal C...rn California to provide protection for cash payin...
Breaking Medicine News(10 mins):Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:MYA Makes Big Brother Stars Amazing! 2Health News:MYA Makes Big Brother Stars Amazing! 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2
... to a survey, mental health wards have been graded... mental health inpatients//. The charity called M...ction over the state of repair of their ward while...ndards of hygiene.Mind is for patients to be treat...
... a voluntary organization helping with the necessi...C), Thiruvananthapuram//. To mark its tenth anniv...ir on Wednesday. He handed over a copy of the souv...n.Mr. Bhatia, who applauded the services provided ...
...ients with schizophrenia whose medication is chang...cts, second-generation// antipsychotic drugs do no... first-generation antipsychotic drugs, according t...ves of General Psychiatry, one of the JAMA/Archive...
...has moles. Most of the time, they are nothing but ...ng cells in moles called melanocytes// start divid...r called melanoma. About one in 65 Americans born ...oma at some point during their lifetime. Scientist...
Other Medicine News:Health News:Mental Health Wards rated unpleasant 2Health News:A decade of service to cancer patients 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 3Health News:Why Don’t All Moles Progress to Melanoma 2Health News:Why Don’t All Moles Progress to Melanoma 3
(Date:8/26/2008)...stCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today anno...om the CUSTOM II trial was published in the most r...rvention. The lead author of the article was,Dr. P...r Utrecht, Utrecht,The Netherlands on behalf of t...across Europe., The one-year CUSTOM II trial, a s...
(Date:8/25/2008).../ -- Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assigne...,the benefit of creditors, announced today that al...d at a sealed bid auction on October 10,2008., S...opa-Carbidopa that,is the current gold standard tr... estimated at approximately $250 million. Signific...
(Date:8/22/2008)..., - Dangerous Bacteria Infect Three Million Peopl...tried can also be innovative: already in,Ancient G...ial. This,ability is now playing an important role... In a worldwide noted field test, a whole hospital...rg, Germany, was equipped with,door handles, door ...
(Date:8/21/2008)...tial in independent study of ad...g. 21 /- A recently published article...ation has expanded our,understanding of the clinic...in adult patients at risk for organ rejection or i...ablo Sanchez-Velasco and his colleagues in the Can...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 2New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 3Commonwealth Fund Commission issues reform recommendations for next president 6383 1Commonwealth Fund Commission issues reform recommendations for next president 6383 2Commonwealth Fund Commission issues reform recommendations for next president 6383 3FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 1FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 2FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 3FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 4BIO key Reports Third Quarter 2007 Results 1228 1BIO key Reports Third Quarter 2007 Results 1228 2BIO key Reports Third Quarter 2007 Results 1228 3BIO key Reports Third Quarter 2007 Results 1228 4BIO key Reports Third Quarter 2007 Results 1228 5Predicting the future in ovarian cancer 6379 1Predicting the future in ovarian cancer 6379 2
...(CCNMatthews - June 14, 2007) - Ambrilia,Biopharma...oping,novel small molecules and peptides to treat ...neral and Special Meeting today, during,which the ...,integrase inhibitors and recent developments were...hairman of the Board, Mr. Frederic,Porte, and a pr...
...atient Trial Show Those Treated with Lumiracoxib,E...ressure Compared,to Ibuprofen, EAST HANOVER, N.J.,...arthritis who also have controlled hypertension ex... pressure when treated with,the investigational se...slight increase in those taking ibuprofen, a commo...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5
...ssional Diagnostics is a leading provider of immun...A test menu that includes kits for autoimmune dise...ellaneous conjugates and components. Our Impact IF...rates and kit sizes to choose from. Kit components...
...ssional Diagnostics is a leading provider of immun...A test menu that includes kits for autoimmune dise...ellaneous conjugates and components. Our Impact IF...rates and kit sizes to choose from. Kit components...
...us disease ELISA products make us a leader in this...ntegration into the busy laboratory, our Infectiou...lity and run-to-run consistency. Our Infectious Di...s for a wide range of serological assays including...
...us disease ELISA products make us a leader in this...ntegration into the busy laboratory, our Infectiou...lity and run-to-run consistency. Our Infectious Di...s for a wide range of serological assays including...
Medicine Products: